Amundi - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 46 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Amundi ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$4,613,740
-9.1%
4,684,000
-10.5%
0.00%0.0%
Q3 2022$5,077,000
+9.3%
5,234,000
+8.5%
0.00%
-25.0%
Q2 2022$4,644,000
+30.5%
4,825,000
+33.1%
0.00%
+100.0%
Q1 2022$3,559,000
-35.5%
3,625,000
-35.0%
0.00%
-33.3%
Q4 2021$5,516,000
-39.1%
5,575,000
-39.5%
0.00%
-50.0%
Q3 2021$9,059,000
-0.1%
9,220,0000.0%0.01%0.0%
Q2 2021$9,064,0009,220,0000.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Opti Capital Management, LP 46,902,000$45,737,0004.40%
INCOME RESEARCH & MANAGEMENT 7,500,000$7,280,0003.12%
TENOR CAPITAL MANAGEMENT Co., L.P. 96,994,000$94,477,0002.13%
PIPER SANDLER & CO. 2,200,000$2,112,0001.92%
DeepCurrents Investment Group LLC 41,092,000$39,934,0001.59%
Radcliffe Capital Management, L.P. 69,010,000$66,983,0001.54%
Sonora Investment Management Group, LLC 9,635,000$9,389,0000.89%
Penn Mutual Asset Management 675,000$656,0000.88%
OAKTREE CAPITAL MANAGEMENT LP 24,447,000$23,851,0000.28%
WOLVERINE ASSET MANAGEMENT LLC 8,681,000$8,429,0000.08%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders